RVP · Retractable Technologies Inc
Market Cap
$21.55M
Shares
29.94M
RVP metrics
66 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.72
Market cap
$21.55M
Price action
19 metricsPrice change (1W)
-2.0%
Price change (30D)
+9.1%
Price change (3M)
+7.5%
Price change (6M)
+4.3%
Price change (YTD)
-6.5%
Price change (1Y)
-14.3%
Trailing year
Price change (5Y)
-94.4%
52-week high
$1.06
52-week low
$0.62
Change from 52-week high
-32.1%
Change from 52-week low
+16.1%
Annualized volatility
46.0%
Beta
0.2
RSI (14D)
57.8
Price vs SMA 50
+3.2%
Price vs SMA 200
+1.1%
Avg volume (3M)
53,426
Relative volume
0.3
Average dollar volume
$37,062
Company
3 metricsSector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
29.94M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.6×
reciprocal yield 157.3%
P / book
0.3
reciprocal yield 338.0%
FCF yield
—
TTM · current market cap
Buyback yield
35.3%
P / FCF
—
P / operating cash flow
—
Earnings yield
-15.6%
Historical valuation
8 metricsP / E historical average (3Y)
15.7×
reciprocal yield 6.4%
P / E historical average (5Y)
15.7×
reciprocal yield 6.4%
EV / revenue historical average (3Y)
0.5×
reciprocal yield 211.0%
EV / revenue historical average (5Y)
0.7×
reciprocal yield 153.7%
EV / EBIT historical average (3Y)
16.1×
reciprocal yield 6.2%
EV / EBIT historical average (5Y)
16.1×
reciprocal yield 6.2%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
35.3%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
-1.4%
Operating margin
-66.9%
Trailing 12 months
Net margin
-9.9%
Gross profit (TTM)
−$491,509
Operating profit (TTM)
−$22.68M
Net income (TTM)
−$3.37M
Trailing 12 months
Diluted EPS (TTM)
$-0.13
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-31.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$33.90M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
-26.1%
Revenue CAGR (5Y)
-14.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-4.6%
Return on assets
-2.4%
Debt / equity
—
Current ratio
4.9
EBITDA (TTM)
−$14.87M
Free cash flow (TTM)
—
Quick ratio
3.7
Interest coverage
-278.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$2.64M
Total assets
$141.69M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$4.96M
Capital expenditures (TTM)
—
R&D (TTM)
$682,033
SG&A (TTM)
—
Stock compensation (TTM)
$672,223
R&D / revenue
2.0%
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
32
13F filer change QoQ
+2
Institutional ownership
8.9%
Short interest
3 metricsShort interest
0.1%
Latest settlement · 1.4 days to cover
Days to cover
1.4d
Short-squeeze score
29 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—